Skip to main content

Table 1 Demographics of SLE and healthy controls

From: Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity

 

SLE patients (n= 42)

Healthy donors (n= 25)

Age (years)

27.4 ± 10.12 (13 to 45)

25.2 ± 9.58 (20 to 42)

Sex(female/male)

39/3

23/2

Disease duration(years)

2.45 ± 2.67

-

Alopecia n (%)

16 (38.1)

-

Mucosal ulcer n (%)

10 (23.8)

-

Malar rash n (%)

26 (61.9)

-

Arthritis n (%)

29 (69.1)

-

Current renal disease n (%)

25 (59.5)

-

Pleuritis n (%)

2 (4.8)

-

Fever n (%)

10 (23.8)

-

Neurological disorder n (%)

2 (4.8)

-

Anemia n (%)

12 (28.6)

-

Thrombocytopenia n (%)

8 (19)

-

Leukopenia n (%)

22 (52.4)

-

ds-DNA n (%)

26 (61.9)

-

AnuA n (%)

20 (47.6)

-

Smith n (%)

10 (23.8)

-

AHA n (%)

20 (47.6)

-

rRNP n (%)

8 (19)

 

ESR

34.05 ± 26.79

-

CRP

5.31 ± 6.44

-

Low C3 n (%)

26 (61.9)

-

Low C4 n (%)

22 (52.4)

-

24-hour urine protein n (%)

22 (52.4) (> 0.5 g/24 h)

-

SLEDAI

4 to 30 (13.9 ± 7.12)

-

  1. Except where otherwise indicated, values are expressed as mean ± standard deviation. There were no significant differences between patients with SLE and healthy donors in terms of age and sex. AHA, anti-histone antibody; AnuA, anti-nucleosome antibody; C3, complement 3; C4, complement 4; CRP, C-reactive protein; ds-DNA, anti-double stranded DNA antibody; ESR, erythrocyte sedimentation rate; rRNP, anti-ribosome ribonucleoprotein antibody; SLE, systemic lupus erythematosus; SLEDAI, SLE disease activity index; Smith, anti-smith-antibody.
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us